Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 152 entries
Sorted by: Best Match Show Resources per page
Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. .

International journal of molecular sciences

Willenbacher E, Khan SZ, Mujica SCA, Trapani D, Hussain S, Wolf D, Willenbacher W, Spizzo G, Seeber A.
PMID: 32785029
Int J Mol Sci. 2020 Aug 10;21(16). doi: 10.3390/ijms21165725.

We would like to change the authors' names and affiliations on Page 1 of paper [...].

Cite
Willenbacher E, Khan SZ, Mujica SCA, et al. Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. . Int J Mol Sci. 2020;21(16)doi: 10.3390/ijms21165725.
Willenbacher, E., Khan, S. Z., Mujica, S. C. A., Trapani, D., Hussain, S., Wolf, D., Willenbacher, W., Spizzo, G., & Seeber, A. (2020). Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. . International journal of molecular sciences, 21(16), . https://doi.org/10.3390/ijms21165725
Willenbacher, Ella, et al. "Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. ." International journal of molecular sciences vol. 21,16 (2020). doi: https://doi.org/10.3390/ijms21165725
Willenbacher E, Khan SZ, Mujica SCA, Trapani D, Hussain S, Wolf D, Willenbacher W, Spizzo G, Seeber A. Erratum: Willenbacher, E., et al. Curcumin: New Insights into an Ancient Ingredient against Cancer. . Int J Mol Sci. 2020 Aug 10;21(16). doi: 10.3390/ijms21165725. PMID: 32785029; PMCID: PMC7461099.
Copy Download .nbib Format: NLM
Feasibility of Routine Quality of Life Measurement for People Living With Dementia in Long-Term Care.

Journal of the American Medical Directors Association

Hoben M, Banerjee S, Beeber AS, Chamberlain SA, Hughes L, O'Rourke HM, Stajduhar K, Shrestha S, Devkota R, Lam J, Simons I, Dymchuk E, Corbett K, Estabrooks CA.
PMID: 34411540
J Am Med Dir Assoc. 2021 Aug 17; doi: 10.1016/j.jamda.2021.07.018. Epub 2021 Aug 17.

OBJECTIVES: Maximizing quality of life (QoL) is the ultimate goal of long-term dementia care. However, routine QoL measurement is rare in nursing home (NH) and assisted living (AL) facilities. Routine QoL measurement might lead to improvements in resident QoL....

Cite
Hoben M, Banerjee S, Beeber AS, et al. Feasibility of Routine Quality of Life Measurement for People Living With Dementia in Long-Term Care. J Am Med Dir Assoc. 2021;doi: 10.1016/j.jamda.2021.07.018.
Hoben, M., Banerjee, S., Beeber, A. S., Chamberlain, S. A., Hughes, L., O'Rourke, H. M., Stajduhar, K., Shrestha, S., Devkota, R., Lam, J., Simons, I., Dymchuk, E., Corbett, K., & Estabrooks, C. A. (2021). Feasibility of Routine Quality of Life Measurement for People Living With Dementia in Long-Term Care. Journal of the American Medical Directors Association, . https://doi.org/10.1016/j.jamda.2021.07.018
Hoben, Matthias, et al. "Feasibility of Routine Quality of Life Measurement for People Living With Dementia in Long-Term Care." Journal of the American Medical Directors Association vol. (2021). doi: https://doi.org/10.1016/j.jamda.2021.07.018
Hoben M, Banerjee S, Beeber AS, Chamberlain SA, Hughes L, O'Rourke HM, Stajduhar K, Shrestha S, Devkota R, Lam J, Simons I, Dymchuk E, Corbett K, Estabrooks CA. Feasibility of Routine Quality of Life Measurement for People Living With Dementia in Long-Term Care. J Am Med Dir Assoc. 2021 Aug 17; doi: 10.1016/j.jamda.2021.07.018. Epub 2021 Aug 17. PMID: 34411540.
Copy Download .nbib Format: NLM
Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families.

Journal of applied gerontology : the official journal of the Southern Gerontological Society

Beeber AS, Zimmerman S, Wretman CJ, Palmertree S, Patel K, Sloane PD.
PMID: 34160299
J Appl Gerontol. 2021 Jun 23;7334648211023678. doi: 10.1177/07334648211023678. Epub 2021 Jun 23.

Antipsychotic medications are frequently prescribed to assisted living (AL) residents who have dementia, although there is a lack of information about the potential side effects and adverse events of these medications among this population. Oversight and monitoring by family...

Cite
Beeber AS, Zimmerman S, Wretman CJ, et al. Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. J Appl Gerontol. 2021;7334648211023678doi: 10.1177/07334648211023678.
Beeber, A. S., Zimmerman, S., Wretman, C. J., Palmertree, S., Patel, K., & Sloane, P. D. (2021). Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. Journal of applied gerontology : the official journal of the Southern Gerontological Society, 7334648211023678. https://doi.org/10.1177/07334648211023678
Beeber, Anna Song, et al. "Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families." Journal of applied gerontology : the official journal of the Southern Gerontological Society vol. (2021): 7334648211023678. doi: https://doi.org/10.1177/07334648211023678
Beeber AS, Zimmerman S, Wretman CJ, Palmertree S, Patel K, Sloane PD. Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. J Appl Gerontol. 2021 Jun 23;7334648211023678. doi: 10.1177/07334648211023678. Epub 2021 Jun 23. PMID: 34160299.
Copy Download .nbib Format: NLM
Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families.

Journal of applied gerontology : the official journal of the Southern Gerontological Society

Beeber AS, Zimmerman S, Wretman CJ, Palmertree S, Patel K, Sloane PD.
PMID: 34160299
J Appl Gerontol. 2021 Jun 23;7334648211023678. doi: 10.1177/07334648211023678. Epub 2021 Jun 23.

Antipsychotic medications are frequently prescribed to assisted living (AL) residents who have dementia, although there is a lack of information about the potential side effects and adverse events of these medications among this population. Oversight and monitoring by family...

Cite
Beeber AS, Zimmerman S, Wretman CJ, et al. Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. J Appl Gerontol. 2021;7334648211023678doi: 10.1177/07334648211023678.
Beeber, A. S., Zimmerman, S., Wretman, C. J., Palmertree, S., Patel, K., & Sloane, P. D. (2021). Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. Journal of applied gerontology : the official journal of the Southern Gerontological Society, 7334648211023678. https://doi.org/10.1177/07334648211023678
Beeber, Anna Song, et al. "Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families." Journal of applied gerontology : the official journal of the Southern Gerontological Society vol. (2021): 7334648211023678. doi: https://doi.org/10.1177/07334648211023678
Beeber AS, Zimmerman S, Wretman CJ, Palmertree S, Patel K, Sloane PD. Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. J Appl Gerontol. 2021 Jun 23;7334648211023678. doi: 10.1177/07334648211023678. Epub 2021 Jun 23. PMID: 34160299; PMCID: PMC8695622.
Copy Download .nbib Format: NLM
[No title available]

Cancers

Zimmer K, Puccini A, Xiu J, Baca Y, Spizzo G, Lenz HJ, Battaglin F, Goldberg RM, Grothey A, Shields AF, Salem ME, Marshall JL, Korn WM, Wolf D, Kocher F, Seeber A.
PMID: 32455893
Cancers (Basel). 2020 May 22;12(5). doi: 10.3390/cancers12051319.

Werner syndrome gene (

Cite
Zimmer K, Puccini A, Xiu J, et al. . Cancers (Basel). 2020;12(5)doi: 10.3390/cancers12051319.
Zimmer, K., Puccini, A., Xiu, J., Baca, Y., Spizzo, G., Lenz, H. J., Battaglin, F., Goldberg, R. M., Grothey, A., Shields, A. F., Salem, M. E., Marshall, J. L., Korn, W. M., Wolf, D., Kocher, F., & Seeber, A. (2020). . Cancers, 12(5), . https://doi.org/10.3390/cancers12051319
Zimmer, Kai, et al. "." Cancers vol. 12,5 (2020). doi: https://doi.org/10.3390/cancers12051319
Zimmer K, Puccini A, Xiu J, Baca Y, Spizzo G, Lenz HJ, Battaglin F, Goldberg RM, Grothey A, Shields AF, Salem ME, Marshall JL, Korn WM, Wolf D, Kocher F, Seeber A. . Cancers (Basel). 2020 May 22;12(5). doi: 10.3390/cancers12051319. PMID: 32455893; PMCID: PMC7281075.
Copy Download .nbib Format: NLM
Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.

BioResearch open access

Tang Q, Keeler AM, Zhang S, Su Q, Lyu Z, Cheng Y, Gao G, Flotte TR.
PMID: 33117614
Biores Open Access. 2020 Oct 16;9(1):219-228. doi: 10.1089/biores.2020.0031. eCollection 2020.

A number of packaging systems are available for production of recombinant adeno-associated virus vectors (rAAVs). Among these, the use of a two-plasmid cotransfection system, in which Rep and Cap genes and Ad helper genes are on the same plasmid,...

Cite
Tang Q, Keeler AM, Zhang S, et al. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. Biores Open Access. 2020;9(1):219-228doi: 10.1089/biores.2020.0031.
Tang, Q., Keeler, A. M., Zhang, S., Su, Q., Lyu, Z., Cheng, Y., Gao, G., & Flotte, T. R. (2020). Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. BioResearch open access, 9(1), 219-228. https://doi.org/10.1089/biores.2020.0031
Tang, Qiushi, et al. "Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus." BioResearch open access vol. 9,1 (2020): 219-228. doi: https://doi.org/10.1089/biores.2020.0031
Tang Q, Keeler AM, Zhang S, Su Q, Lyu Z, Cheng Y, Gao G, Flotte TR. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. Biores Open Access. 2020 Oct 16;9(1):219-228. doi: 10.1089/biores.2020.0031. eCollection 2020. PMID: 33117614; PMCID: PMC7590824.
Copy Download .nbib Format: NLM
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.

Therapeutic advances in medical oncology

Müller M, Posch F, Kiem D, Barth D, Horvath L, Stotz M, Schaberl-Moser R, Pichler M, Greil R, Jost PJ, Seeber A, Amann A, Schlick K, Gerger A, Riedl JM.
PMID: 34616490
Ther Adv Med Oncol. 2021 Sep 30;13:17588359211039930. doi: 10.1177/17588359211039930. eCollection 2021.

BACKGROUND: The level of evidence for palliative second-line therapy in advanced esophageal squamous cell carcinoma (aESCC) is limited. This is the first study that reports efficacy data comparing second-line therapy + active symptom control (ASC) METHODS: We conducted a...

Cite
Müller M, Posch F, Kiem D, et al. Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis. Ther Adv Med Oncol. 2021;13:17588359211039930doi: 10.1177/17588359211039930.
Müller, M., Posch, F., Kiem, D., Barth, D., Horvath, L., Stotz, M., Schaberl-Moser, R., Pichler, M., Greil, R., Jost, P. J., Seeber, A., Amann, A., Schlick, K., Gerger, A., & Riedl, J. M. (2021). Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis. Therapeutic advances in medical oncology, 1317588359211039930. https://doi.org/10.1177/17588359211039930
Müller, Moritz, et al. "Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis." Therapeutic advances in medical oncology vol. 13 (2021): 17588359211039930. doi: https://doi.org/10.1177/17588359211039930
Müller M, Posch F, Kiem D, Barth D, Horvath L, Stotz M, Schaberl-Moser R, Pichler M, Greil R, Jost PJ, Seeber A, Amann A, Schlick K, Gerger A, Riedl JM. Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis. Ther Adv Med Oncol. 2021 Sep 30;13:17588359211039930. doi: 10.1177/17588359211039930. eCollection 2021. PMID: 34616490; PMCID: PMC8488508.
Copy Download .nbib Format: NLM
THE CONSTRAINING EFFECT OF THE LATERAL FEMORAL INTERMUSCULAR SEPTUM ON PASSIVE HIP ADDUCTION IN UN-EMBALMED CADAVERS.

International journal of sports physical therapy

Seeber GH, Lierly M, Bassett C, Douthit C, Wilhelm M, Matthijs A, Matthijs O, Lazovic D, Brismée JM, Gilbert K, Sizer P.
PMID: 32089957
Int J Sports Phys Ther. 2020 Feb;15(1):42-52.

BACKGROUND: Due to the lack of verifiable iliotibial band elongation in response to stretching, the anatomical, biomechanical, and physiological responses to treatment of iliotibial band syndrome remain unclear. The lateral intermuscular septum, consisting of multiple myofibroblasts, firmly anchors the...

Cite
Seeber GH, Lierly M, Bassett C, et al. THE CONSTRAINING EFFECT OF THE LATERAL FEMORAL INTERMUSCULAR SEPTUM ON PASSIVE HIP ADDUCTION IN UN-EMBALMED CADAVERS. Int J Sports Phys Ther. 2020;15(1):42-52
Seeber, G. H., Lierly, M., Bassett, C., Douthit, C., Wilhelm, M., Matthijs, A., Matthijs, O., Lazovic, D., Brismée, J. M., Gilbert, K., & Sizer, P. (2020). THE CONSTRAINING EFFECT OF THE LATERAL FEMORAL INTERMUSCULAR SEPTUM ON PASSIVE HIP ADDUCTION IN UN-EMBALMED CADAVERS. International journal of sports physical therapy, 15(1), 42-52.
Seeber, Gesine H, et al. "THE CONSTRAINING EFFECT OF THE LATERAL FEMORAL INTERMUSCULAR SEPTUM ON PASSIVE HIP ADDUCTION IN UN-EMBALMED CADAVERS." International journal of sports physical therapy vol. 15,1 (2020): 42-52.
Seeber GH, Lierly M, Bassett C, Douthit C, Wilhelm M, Matthijs A, Matthijs O, Lazovic D, Brismée JM, Gilbert K, Sizer P. THE CONSTRAINING EFFECT OF THE LATERAL FEMORAL INTERMUSCULAR SEPTUM ON PASSIVE HIP ADDUCTION IN UN-EMBALMED CADAVERS. Int J Sports Phys Ther. 2020 Feb;15(1):42-52. PMID: 32089957; PMCID: PMC7015031.
Copy Download .nbib Format: NLM
Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives.

Cancers

Mukherji R, Marshall JL, Seeber A.
PMID: 32707813
Cancers (Basel). 2020 Jul 22;12(8). doi: 10.3390/cancers12082001.

The selection of treatment according to genomic alterations is a standard approach in metastatic colorectal cancer but is only starting to have an impact in the earlier stages of the disease. The status if genes like

Cite
Mukherji R, Marshall JL, Seeber A. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers (Basel). 2020;12(8)doi: 10.3390/cancers12082001.
Mukherji, R., Marshall, J. L., & Seeber, A. (2020). Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers, 12(8), . https://doi.org/10.3390/cancers12082001
Mukherji, Reetu, et al. "Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives." Cancers vol. 12,8 (2020). doi: https://doi.org/10.3390/cancers12082001
Mukherji R, Marshall JL, Seeber A. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers (Basel). 2020 Jul 22;12(8). doi: 10.3390/cancers12082001. PMID: 32707813; PMCID: PMC7465976.
Copy Download .nbib Format: NLM
Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies.

Computational and structural biotechnology journal

Zimmer K, Kocher F, Spizzo G, Salem M, Gastl G, Seeber A.
PMID: 31007870
Comput Struct Biotechnol J. 2019 Mar 26;17:447-453. doi: 10.1016/j.csbj.2019.03.012. eCollection 2019.

In this review we aim to summarize studies investigating the impact of a molecular profiling (MP)-guided treatment approach in heavily pretreated cancer patients. In summary, many independent single- and multicenter studies showed a significant benefit of MP-guided treatment regarding...

Cite
Zimmer K, Kocher F, Spizzo G, et al. Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies. Comput Struct Biotechnol J. 2019;17:447-453doi: 10.1016/j.csbj.2019.03.012.
Zimmer, K., Kocher, F., Spizzo, G., Salem, M., Gastl, G., & Seeber, A. (2019). Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies. Computational and structural biotechnology journal, 17447-453. https://doi.org/10.1016/j.csbj.2019.03.012
Zimmer, Kai, et al. "Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies." Computational and structural biotechnology journal vol. 17 (2019): 447-453. doi: https://doi.org/10.1016/j.csbj.2019.03.012
Zimmer K, Kocher F, Spizzo G, Salem M, Gastl G, Seeber A. Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies. Comput Struct Biotechnol J. 2019 Mar 26;17:447-453. doi: 10.1016/j.csbj.2019.03.012. eCollection 2019. PMID: 31007870; PMCID: PMC6453774.
Copy Download .nbib Format: NLM
Are non-monetary rewards effective in attracting peer reviewers? A natural experiment.

Scientometrics

Zaharie MA, Seeber M.
PMID: 30546171
Scientometrics. 2018;117(3):1587-1609. doi: 10.1007/s11192-018-2912-6. Epub 2018 Sep 20.

Editors of scientific journals meet increasing challenges to find peer reviewers. Rewarding reviewers has been proposed as a solution to incentives peer review, and journals have already started to offer different kinds of rewards, particularly non-monetary ones. However, research...

Cite
Zaharie MA, Seeber M. Are non-monetary rewards effective in attracting peer reviewers? A natural experiment. Scientometrics. 2018;117(3):1587-1609doi: 10.1007/s11192-018-2912-6.
Zaharie, M. A., & Seeber, M. (2018). Are non-monetary rewards effective in attracting peer reviewers? A natural experiment. Scientometrics, 117(3), 1587-1609. https://doi.org/10.1007/s11192-018-2912-6
Zaharie, Monica Aniela, and Seeber, Marco. "Are non-monetary rewards effective in attracting peer reviewers? A natural experiment." Scientometrics vol. 117,3 (2018): 1587-1609. doi: https://doi.org/10.1007/s11192-018-2912-6
Zaharie MA, Seeber M. Are non-monetary rewards effective in attracting peer reviewers? A natural experiment. Scientometrics. 2018;117(3):1587-1609. doi: 10.1007/s11192-018-2912-6. Epub 2018 Sep 20. PMID: 30546171; PMCID: PMC6267241.
Copy Download .nbib Format: NLM
Assessment of Basic Motions and Technique Identification in Classical Cross-Country Skiing.

Frontiers in psychology

Tjønnås J, Seeberg TM, Rindal OMH, Haugnes P, Sandbakk Ø.
PMID: 31231279
Front Psychol. 2019 Jun 07;10:1260. doi: 10.3389/fpsyg.2019.01260. eCollection 2019.

Cross-country skiing is a popular Olympic winter sport, which is also used extensively as a recreational activity. While cross-country skiing primarily is regarded as a demanding endurance activity it is also technically challenging, as it contains two main styles...

Cite
Tjønnås J, Seeberg TM, Rindal OMH, et al. Assessment of Basic Motions and Technique Identification in Classical Cross-Country Skiing. Front Psychol. 2019;10:1260doi: 10.3389/fpsyg.2019.01260.
Tjønnås, J., Seeberg, T. M., Rindal, O. M. H., Haugnes, P., & Sandbakk, �. �. (2019). Assessment of Basic Motions and Technique Identification in Classical Cross-Country Skiing. Frontiers in psychology, 101260. https://doi.org/10.3389/fpsyg.2019.01260
Tjønnås, Johannes, et al. "Assessment of Basic Motions and Technique Identification in Classical Cross-Country Skiing." Frontiers in psychology vol. 10 (2019): 1260. doi: https://doi.org/10.3389/fpsyg.2019.01260
Tjønnås J, Seeberg TM, Rindal OMH, Haugnes P, Sandbakk Ø. Assessment of Basic Motions and Technique Identification in Classical Cross-Country Skiing. Front Psychol. 2019 Jun 07;10:1260. doi: 10.3389/fpsyg.2019.01260. eCollection 2019. PMID: 31231279; PMCID: PMC6566644.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 152 entries